Jane Huang Insider Trading $BGNE BeiGene, Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane Huang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Huang. Jane Huang is CMO, Hematology in BeiGene, Ltd. ($BGNE).
Jane Huang in BeiGene, Ltd.
Trading Symbol: BGNEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jane Huang: CMO, Hematology
Holdings: 1,500 shares
Current Value: $53,880
Latest Transaction: May 03 2021
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jane Huang in BeiGene, Ltd.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 144.41 | 2,632 | 380,083 | 230 | 2.9 K to 230 (-91.96 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 32,500 | 113,425 | 850,465 | |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 136.91 | 500 | 68,454 | 0 | 500 to 0 (-100.00 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 135.86 | 800 | 108,686 | 500 | 1.3 K to 500 (-61.54 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 134.34 | 400 | 53,736 | 1,300 | 1.7 K to 1.3 K (-23.53 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 132.47 | 800 | 105,979 | 1,700 | 2.5 K to 1.7 K (-32.00 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 2,500 | 113,275 | 2,500 | 0 to 2.5 K |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 32,500 | 113,425 | 850,465 | |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 136.91 | 500 | 68,454 | 0 | 500 to 0 (-100.00 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 135.86 | 800 | 108,686 | 500 | 1.3 K to 500 (-61.54 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 134.34 | 400 | 53,736 | 1,300 | 1.7 K to 1.3 K (-23.53 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 132.47 | 800 | 105,979 | 1,700 | 2.5 K to 1.7 K (-32.00 %) |
Aug 13 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 2,500 | 113,275 | 2,500 | 0 to 2.5 K |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 66,690 | 151,386 | 1,044,775 | |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 65,000 | 226,850 | 882,965 | |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 135.10 | 7,630 | 1,030,821 | 0 | 7.6 K to 0 (-100.00 %) |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 132.83 | 2,500 | 332,075 | 7,630 | 10.1 K to 7.6 K (-24.68 %) |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 5,130 | 151,284 | 10,130 | 5 K to 10.1 K (+102.60 %) |
Jul 31 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 5,000 | 226,550 | 5,000 | 0 to 5 K |
Jul 01 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 126.33 | 3 | 379 | 0 | 3 to 0 (-100.00 %) |
Jul 01 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 124.50 | 427 | 53,163 | 3 | 430 to 3 (-99.30 %) |
Jun 07 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 9.23 | 462,579 | 4,269,604 | 462,579 | |
Jun 07 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 62,842 | 0 | 334,463 | 271.6 K to 334.5 K (+23.14 %) |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 28,600 | 99,814 | 947,965 | |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 3,900 | 13,611 | 976,565 | |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 130.06 | 2,200 | 286,132 | 0 | 2.2 K to 0 (-100.00 %) |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 2,200 | 99,682 | 2,200 | 0 to 2.2 K |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 130.12 | 300 | 39,036 | 0 | 300 to 0 (-100.00 %) |
May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 300 | 13,593 | 300 | 0 to 300 |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 183,690 | 416,976 | 1,111,465 | |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 145.94 | 147 | 21,453 | 0 | 147 to 0 (-100.00 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 144.90 | 1,281 | 185,617 | 147 | 1.4 K to 147 (-89.71 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 143.72 | 2,304 | 331,132 | 1,428 | 3.7 K to 1.4 K (-61.74 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 142.73 | 6,159 | 879,060 | 3,732 | 9.9 K to 3.7 K (-62.27 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 141.80 | 3,439 | 487,662 | 9,891 | 13.3 K to 9.9 K (-25.80 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 140.49 | 800 | 112,390 | 13,330 | 14.1 K to 13.3 K (-5.66 %) |
Apr 10 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 14,130 | 416,694 | 14,130 | 0 to 14.1 K |
Mar 11 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 33,345 | 75,693 | 1,295,155 | |
Mar 11 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 130.00 | 2,565 | 333,450 | 0 | 2.6 K to 0 (-100.00 %) |
Mar 11 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 2,565 | 75,642 | 2,565 | 0 to 2.6 K |
Mar 11 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 140.50 | 71 | 9,976 | 0 | 71 to 0 (-100.00 %) |
Nov 28 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 39,000 | 88,530 | 1,328,500 | |
Nov 28 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 139.58 | 3,000 | 418,750 | 0 | 3 K to 0 (-100.00 %) |
Nov 28 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 3,000 | 88,470 | 3,000 | 0 to 3 K |
Sep 05 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 174.60 | 2,911 | 508,247 | 0 | 2.9 K to 0 (-100.00 %) |
Jun 28 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 12.34 | 310,180 | 3,827,621 | 310,180 | |
Jun 28 2018 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 44,564 | 0 | 309,464 | 264.9 K to 309.5 K (+16.82 %) |
Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 13,000 | 29,510 | 1,367,500 | |
Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 98.00 | 1,000 | 98,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.51 | 1,000 | 29,510 | 1,000 | 0 to 1,000 |
Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 1,380,500 | |
Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 94.53 | 200 | 18,906 | 0 | 200 to 0 (-100.00 %) |
Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 94.21 | 1,300 | 122,475 | 200 | 1.5 K to 200 (-86.67 %) |
Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.51 | 1,500 | 44,265 | 1,500 | 0 to 1.5 K |
Dec 05 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 86.00 | 1,100 | 94,600 | 0 | 1.1 K to 0 (-100.00 %) |
Nov 20 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 87.00 | 1,000 | 87,000 | 1,100 | 2.1 K to 1.1 K (-47.62 %) |
Nov 20 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 85.00 | 600 | 51,000 | 2,100 | 2.7 K to 2.1 K (-22.22 %) |
Jun 29 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 3.49 | 980,465 | 3,421,823 | 980,465 | |
Sep 07 2016 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 2.27 | 1,400,000 | 3,178,000 | 1,400,000 | |
Sep 07 2016 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |